ACURA PHARMACEUTICALS, INC
ACURAcura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR".
Drugs in Pipeline
4
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
Acurox 5/30 mg
Pain
Acurox 5/30mg taken first
Opioid Abuse
40/0mg taken first
Opioid Abuse
Generic H/A taken first
Opioid-Related Disorders
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Acurox 5/30 mg | Phase 3 | Pain | - | - |
Acurox 5/30mg taken first | Phase 2 | Opioid Abuse | - | - |
40/0mg taken first | Phase 2 | Opioid Abuse | - | - |
Generic H/A taken first | Phase 2 | Opioid-Related Disorders | - | - |
Frequently asked questions
What is in ACURA PHARMACEUTICALS, INC's drug pipeline?→
CatalystAlert tracks 4 drug candidates in ACURA PHARMACEUTICALS, INC's (ACUR) pipeline across Phase 3, Phase 2. Its lead program is Acurox 5/30 mg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ACURA PHARMACEUTICALS, INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ACURA PHARMACEUTICALS, INC (ACUR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ACUR biotech catalysts?→
Add ACUR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ACURA PHARMACEUTICALS, INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.